166 related articles for article (PubMed ID: 18636260)
1. Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation.
Sugita J; Tanaka J; Hashimoto A; Shiratori S; Yasumoto A; Wakasa K; Kikuchi M; Shigematsu A; Miura Y; Tsutsumi Y; Kondo T; Asaka M; Imamura M
Ann Hematol; 2008 Dec; 87(12):1003-8. PubMed ID: 18636260
[TBL] [Abstract][Full Text] [Related]
2. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
[TBL] [Abstract][Full Text] [Related]
3. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
[TBL] [Abstract][Full Text] [Related]
4. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.
Valcárcel D; Martino R; Caballero D; Mateos MV; Pérez-Simón JA; Canals C; Fernández F; Bargay J; Muñiz-Díaz E; Gonzalez M; San Miguel JF; Sierra J
Bone Marrow Transplant; 2003 Mar; 31(5):387-92. PubMed ID: 12634730
[TBL] [Abstract][Full Text] [Related]
5. CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation.
Mohr B; Koch R; Thiede C; Kroschinsky F; Ehninger G; Bornhäuser M
Bone Marrow Transplant; 2004 Dec; 34(11):949-54. PubMed ID: 15489870
[TBL] [Abstract][Full Text] [Related]
6. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
[TBL] [Abstract][Full Text] [Related]
7. Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation.
Saito T; Kanda Y; Nakai K; Kim SW; Arima F; Kami M; Tanosaki R; Tobinai K; Wakasugi H; Heike Y; Mineishi S; Takaue Y
Bone Marrow Transplant; 2003 Sep; 32(6):601-8. PubMed ID: 12953133
[TBL] [Abstract][Full Text] [Related]
8. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
[TBL] [Abstract][Full Text] [Related]
9. Poor engraftment after allogeneic bone marrow transplantation: role of chimerism analysis in treatment and outcome.
Au WY; Chan EC; Lie AK; Liang R; Leung AY; Ma SK; Kwong YL
Ann Hematol; 2003 Jul; 82(7):410-5. PubMed ID: 12750845
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism.
Savage WJ; Bleesing JJ; Douek D; Brown MR; Linton GM; Malech HL; Horwitz ME
Bone Marrow Transplant; 2001 Sep; 28(5):463-71. PubMed ID: 11593319
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
Villaron EM; Almeida J; López-Holgado N; Alcoceba M; Sánchez-Abarca LI; Sanchez-Guijo FM; Alberca M; Pérez-Simon JA; San Miguel JF; Del Cañizo MC
Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390
[TBL] [Abstract][Full Text] [Related]
12. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
[TBL] [Abstract][Full Text] [Related]
13. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.
Goebel WS; Pech NK; Meyers JL; Srour EF; Yoder MC; Dinauer MC
Exp Hematol; 2004 Dec; 32(12):1255-64. PubMed ID: 15588950
[TBL] [Abstract][Full Text] [Related]
14. [Mini-transplantation from cord blood].
Miyakoshi S
Nihon Rinsho; 2003 Sep; 61(9):1555-60. PubMed ID: 14515723
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene.
Wang LJ; Chou P; Gonzalez-Ryan L; Huang W; Haut PR; Kletzel M
Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144
[TBL] [Abstract][Full Text] [Related]
16. [The kinetics of hematopoietic cell chimerism in the early period after non-myeloablative transplantation and its clinical implications].
Xiao XB; Sun QY; Guo M; Qiao JH; Yu CL; Ai HS
Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):466-9. PubMed ID: 15555261
[TBL] [Abstract][Full Text] [Related]
17. Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors.
Sanchez-Guijo FM; Sanchez-Abarca LI; Bueno C; Villaron E; Lopez-Holgado N; Vazquez L; Lopez-Fidalgo J; Perez-Simon JA; Caballero MD; del Cañizo MC; Orfao A; San Miguel JF
Biol Blood Marrow Transplant; 2005 May; 11(5):354-61. PubMed ID: 15846289
[TBL] [Abstract][Full Text] [Related]
18. [DNA polymorphism, allogenic bone marrow transplantation and peripheral cell chimerism].
Brdicka R; Sieglová Z; Honzátková L; Dvoráková R; Hrabánek J; Kobylka P; Vítek A; Sedlácek P; Starý J
Cas Lek Cesk; 1998 Feb; 137(4):110-9. PubMed ID: 9531733
[TBL] [Abstract][Full Text] [Related]
19. Successful non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT) for Waldenström's macroglobulinemia with severe pancytopenia.
Ueda T; Hatanaka K; Kosugi S; Kishino BI; Tamaki T
Bone Marrow Transplant; 2001 Sep; 28(6):609-11. PubMed ID: 11607775
[TBL] [Abstract][Full Text] [Related]
20. [Allogenic bone marrow transplantation after reduced intensity conditioning regimens in therapy of patients with hemoblastoses].
Demidova IA; Savchenko VG; Ol'shanskaia IuV; Poreshina LP; Kut'ina RM; Surin VL; Misiurin AV; Domracheva EV; Parovichnikova EN
Ter Arkh; 2003; 75(7):15-21. PubMed ID: 12934475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
